Recent rare disease approvals show the US FDA is still willing to accept a range of confirmatory evidence when randomized controlled trials are not feasible (Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
